Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
GLP-1
Biotech
Madrigal pens $2B deal for CSPC's GLP-1, eyes Rezdiffra pairing
Madrigal is paying $120 million upfront for a preclinical GLP-1 agonist the biopharma plans to pair with its fatty liver disease med Rezdiffra.
James Waldron
Jul 30, 2025 7:35am
Fierce Pharma
Novo Nordisk names new CEO as it cuts sales, profit outlook
Jul 29, 2025 10:10am
Mice given a brain protein lost weight without getting nauseous
Jul 24, 2025 7:00am
Hengrui's GLP-1/GIP agonist posts 18% weight loss in ph. 3 trial
Jul 15, 2025 9:17am
Altimmune stock sinks on mixed ph. 2 MASH results for GLP-1 drug
Jun 26, 2025 8:41am
BrightGene tops Novo drug in diabetes ahead of Zepbound showdown
Jun 23, 2025 2:30pm
